CD19-targeted chimeric antigen receptor T-cell therapy for CNS relapsed or refractory acute lymphocytic leukaemia: a post-hoc analysis of pooled data from five clinical trials

Allison Barz Leahy, Haley Newman, Yimei Li, Hongyan Liu, Regina M. Myers, Amanda M. DiNofia, J. Gregory Dolan, Colleen Callahan, Diane Baniewicz, Kaitlin J. Devine, Lisa Wray, Richard Aplenc, Carl H. June, Stephan A. Grupp, Susan R. Rheingold, Shannon L. Maude